CoChat

β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis

Open access
Murray, Patrick S., Kirkwood, Caitlin M., Gray, Megan C., Ikonomovic, Milos D., Paljug, William R., Abrahamson, Eric E., Henteleff, Ruth A., Hamilton, Ronald L., Kofler, Julia K., Klunk, William E., Lopez, Oscar L., Penzes, Peter, Sweet, Robert A. · 2012 · Neurobiology of Aging
Cited by 54

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Psychosis in Alzheimer disease differentiates a subgroup with more rapid decline, is heritable, and aggregates within families, suggesting a distinct neurobiology. Evidence indicates that greater impairments of cerebral cortical synapses, particularly in dorsolateral prefrontal cortex, may contribute to the pathogenesis of psychosis in AD phenotype. Soluble β-amyloid induces loss of dendritic spine synapses through impairment of long term potentiation. In contrast, the Rho GEF kalirin is an essential mediator of spine maintenance and growth in cerebral cortex. We therefore hypothesized that psychosis in AD would be associated with increased soluble β-amyloid and reduced expression of kalirin in the cortex. We tested this hypothesis in postmortem cortical gray matter extracts from fifty-two AD subjects with and without psychosis. In subjects with psychosis, the β-amyloid1-42/β-amyloid1-40 ratio was increased, due primarily to reduced soluble β-amyloid1-40, and kalirin-7, -9, and -12 were reduced. These findings suggest that increased cortical β-amyloid1-42/β-amyloid1-40 ratio and decreased kalirin expression may both contribute to the pathogenesis of psychosis in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2012.02.015

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 54

Metadata

Authors
Murray, P. S., Kirkwood, C. M., Gray, M. C., Ikonomovic, M. D., Paljug, W. R., Abrahamson, E. E., Henteleff, R. A., Hamilton, R. L., Kofler, J. K., Klunk, W. E., Lopez, O. L., Penzes, P., & Sweet, R. A.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2012-12
Volume
33
Issue
12
Pages
2807-2816
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2061565534
Cited by
54
References
27
FWCI
3.21
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2012.02.015
The paper
Murray, P. S., Kirkwood, C. M., Gray, M. C., Ikonomovic, M. D., Paljug, W. R., Abrahamson, E. E., Henteleff, R. A., Hamilton, R. L., Kofler, J. K., Klunk, W. E., Lopez, O. L., Penzes, P., & Sweet, R. A. (2012). β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2012.02.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.